Souhaitez-vous accéder aux communiqués récents ?

Pressmeddelande, Helsingfors 23 november 2018 kl. 21.00  Antal aktier i Nexstim Abp efter första momentet i processen för att minska antalet aktier Extrastämman av Nexstim Abp (NXTMH:HEX,...

                                                     Company announcement, Helsinki, 23 November 2018 at 21:00  Quantity of shares in Nexstim Plc after completion of the first phase in reducing the...

LIVINGSTON, N.J., Nov. 23, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise...

NEW YORK, Nov. 23, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you...

  Bagsværd, den 23. november 2018 - Novo Nordisk offentliggør i dag de overordnede resultater fra PIONEER 6, det sidste globale fase 3a-studie med oral semaglutid, en ny GLP-1 analog under...

  Bagsværd, Denmark, 23 November 2018 - Novo Nordisk today announced the headline results from the last global phase 3a trial, PIONEER 6, for oral semaglutide, an investigational GLP-1 analogue...

DALLAS, Texas, Nov. 23, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) (“PURA”) with Kail, Inc. (USOTC: KALY) (“KALY”) and Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV)...

Dublin, Nov. 23, 2018 (GLOBE NEWSWIRE) -- The "United States Food Allergen Testing Market, Food Sources, by Treatment & Services, Age Groups and Patient Numbers" report has been added to ...

Dublin, Nov. 23, 2018 (GLOBE NEWSWIRE) -- The "Global Intravenous (IV) Iron Drugs Market: Size, Trends and Forecasts (2018-2022)" report has been added to ResearchAndMarkets.com's ...

Curetis veröffentlicht Ergebnisse für die ersten neun Monate 2018 - Umsatzwachstum weltweit 43% im Jahresvergleich, 207% in den EMEA Direktvertriebsmärkten - Starke Dynamik am US-Markt nach...

Curetis Announces Financial Results for the First Nine Months of 2018 - Total year-on-year revenue growth of 43% globally, 207% in EMEA direct selling markets  - Initial traction in U.S. market...

LUXTURNA is first gene therapy for a genetic disease approved in both the U.S. and EU LUXTURNA is first and only gene therapy approved in EU for patients with an inherited retinal disease (IRD)  ...

Curetis: Positives FDA Feedback beschleunigt  Vorbereitung des 510(k) Zulassungsantrags für zusätzlichen Probentyp der Unyvero LRT US-FDA und Curetis einigen sich auf 510(k)-Anforderungen für...

    Curetis Accelerates 510(k) Submission Preparation for Unyvero LRT in BAL Specimen Based on Positive FDA Feedback U.S. FDA and Curetis agree on 510(k) requirements for clearing BAL as additional...

RADNOR, Pa., Nov. 22, 2018 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP reminds Alnylam Pharmaceuticals, Inc. (Nasdaq:  ALNY) (“Alnylam”) investors that a securities fraud class action...

ORLEANS, Ontario, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to update the...

Selbyville, Delaware, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Pleated HVAC filters market demand will cross USD 2.5 billion up to 2024. These filters have low pressure drops and are efficient having...

BROSSARD, Québec, 21 nov. 2018 (GLOBE NEWSWIRE) -- DIAGNOS inc. (« DIAGNOS », la « Société » ou « l’Émetteur ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un leader dans le dépistage...

SAN MATEO, Calif. and MILLIS, Mass., Nov. 21, 2018 (GLOBE NEWSWIRE) -- Crop One Holdings (“Crop One” or “the Company”), the world’s largest vertical farm operator through its FreshBox Farms brand,...

BROSSARD, Québec, 21 nov. 2018 (GLOBE NEWSWIRE) -- DIAGNOS inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un leader dans le dépistage précoce de...

Approval based on two studies that showed durable remissions in people with newly-diagnosed acute myeloid leukaemia, who are age 75 years or older, or for those ineligible for intensive induction...

Approval based on two studies that showed durable remissions in people with newly-diagnosed acute myeloid leukaemia, who are age 75 years or older, or for those ineligible for intensive induction...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Communiqué de Presse Point d'activité...

IRVINE, Calif., Nov. 21, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Cannabis Science, Inc. (USOTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased...

Freehold, NJ, Nov. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA...

NEW YORK, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Cambridge, UK and Indianapolis, US -...

IRVINE, CA, Nov. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...

CHARLOTTESVILLE, Va., Nov. 21, 2018 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of treatments for...

VANCOUVER, British Columbia, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the appointment of Ingredient...

Pressmeddelande, Helsingfors 21 november 2018 kl. 14.00 Nexstim Abp:s beslut av extrastämman Nexstim Abp (NXTMH:HEX, NXTMS:STO), ett företag inom riktad neuromodulering som tagit fram och...

Company announcement, Helsinki, 21 November 2018 at 2:00 PM Nexstim Plc's resolutions of the Extraordinary General Meeting of Shareholders Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted...

MONTRÉAL, 21 nov. 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), une société biopharmaceutique au stade clinique proposant des traitements novateurs pour les personnes...

MONTREAL, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), a clinical-stage biopharmaceutical company innovating treatments for people with ultra-rare bone disorders...

Fas III-protokollet omarbetas efter IBTs möte med FDA  Igår eftermiddag (amerikansk EST) hade Infant Bacterial Therapeutics ett möte med amerikanska Food and Drug Administration (FDA) i Washington DC...

The Phase III study protocol is modified after IBT’s meeting with the FDA Yesterday afternoon (EST) Infant Bacterial Therapeutics had a meeting with the US Food and Drug Administration (FDA) in...

MONT-SAINT-GUIBERT, Belgium, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T...

Research Triangle Park, NC, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), an emerging specialty pharmaceutical company commercializing therapies that leverage its...

RANCHO CUCAMONGA, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO will be presenting at the 30th Annual Piper Jaffray...

AUSTIN, Texas, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical-based women’s health company focused on gynecologic disease, today announced that Valerie Palmieri,...

PLAINSBORO, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced one of the first surgeries...

NORTHVALE, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...

WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,130,810 titled...

LYON, France, November 20, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will provide a corporate overview at the Piper Jaffray Conference,...

FLORHAM PARK, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Hisamitsu America, a division of Hisamitsu Pharmaceutical Co., Inc., and the marketers of the Salonpas® line of pain relieving products,...

Dublin, Nov. 20, 2018 (GLOBE NEWSWIRE) -- The "Global Wound Therapy Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The wound therapy...

Zug, Switzerland, November 20, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...

Salt Lake City, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today that it has appointed bio-pharma executive, Mr. Stephan Jackman, as its new Chief...

IRVINE, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health,...

Santa Monica, CA, Nov. 20, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...